Malignant Oropharyngeal Neoplasm — Trials

Malignant Oropharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

461 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 143
Recruiting: 77
Ph III recruiting: 7
Growth YoY: −7.7%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (67)

clinicaltrialsPublishedShowing 451–461 of 461 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00068497	Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer	completed	N/A	40	National Cancer Institute (NCI)NIH	1	Jan 14, 2013	clinicaltrials
NCT00063895	Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck	completed	Phase 1 / Phase 2	80	National Cancer Institute (NCI)NIH	1	Jan 9, 2013	clinicaltrials